In this study, we used immunodeficient (i.e., Rag2-/-) transgenic GFAP-luc mice [5] to grow orthotopic brain tumors and to monitor the co-activation of the GFAP promoter with tumor development. The gene discussed is RAG2; the disease is neoplasm.